- All sections
- C - Chemistrymetallurgy
- C07F - Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
- C07F 9/6558 - Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
Patent holdings for IPC class C07F 9/6558
Total number of patents in this class: 1313
10-year publication summary
|
104
|
95
|
115
|
86
|
101
|
88
|
107
|
123
|
103
|
58
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Gilead Sciences, Inc. | 2220 |
41 |
| Achillion Pharmaceuticals, Inc. | 157 |
34 |
| Bristol-myers Squibb Company | 4729 |
23 |
| Sarepta Therapeutics, Inc. | 387 |
22 |
| Rigel Pharmaceuticals, Inc. | 507 |
21 |
| Merck Sharp & Dohme LLC | 3735 |
18 |
| The Regents of the University of California | 20720 |
17 |
| Takeda Pharmaceutical Company Limited | 2715 |
15 |
| Eisai R&D Management Co., Ltd. | 1166 |
15 |
| Samsung Display Co., Ltd. | 38570 |
14 |
| Alkermes Pharma Ireland Limited | 254 |
13 |
| Hangzhou DAC Biotech Co., Ltd | 113 |
12 |
| Ventana Medical Systems, Inc. | 1068 |
11 |
| Boehringer Ingelheim International GmbH | 4493 |
10 |
| Sony Group Corporation | 15597 |
10 |
| Medivir AB | 111 |
9 |
| Sumitomo Pharma Oncology, Inc. | 51 |
9 |
| Centre National de La Recherche Scientifique | 11016 |
8 |
| Nippon Shinyaku Co., Ltd. | 322 |
8 |
| Oxular Acquisitions Limited | 21 |
8 |
| Other owners | 995 |